Your A1C tells you what your average blood sugar has been over the past two to three months. Your kidney labs (eGFR, creatinine, urine ACR) tell you what that blood sugar has been doing to your kidneys over years. Read separately, both are useful. Read together, they tell a story — and the story is what most engaged diabetics need to understand their trajectory. This post covers what A1C actually measures, how A1C trends correlate with kidney changes, what to track at home between labs, how to interpret changes across years, and how these two sets of numbers should shape your management.
If your A1C is well-controlled but your kidney labs are drifting, there's useful information in that gap. If they're moving together, that's useful too.
What A1C measures (and what it doesn't)
HbA1c (hemoglobin A1c) measures the percentage of your red blood cells that have glucose attached, which reflects average blood sugar over roughly 2 to 3 months. According to the American Diabetes Association, A1C is the standard long-term marker of diabetes control.
A few important caveats about A1C:
It's an average, not a peak. An A1C of 7.0% can reflect steady blood sugar hovering around 154 mg/dL, or it can reflect highs of 250 balanced by lows of 60. These represent very different metabolic situations with different kidney implications. A CGM fills in the variability picture; A1C alone doesn't.
It can be skewed by red blood cell turnover. Conditions that affect red blood cell lifespan (chronic kidney disease itself, certain anemias, recent blood loss, hemoglobin variants) can make A1C misleadingly low or high. For patients with significant kidney disease, A1C may underestimate actual blood sugar levels.
It reflects what already happened. A1C tells you about the last 2 to 3 months. Changes you make today show up in 6 to 12 weeks, not immediately.
For most patients, A1C is still the best long-term control marker available. For patients with kidney disease, it should be interpreted alongside time-in-range data from CGMs when possible and alongside other markers.
Target A1C for most adults with diabetes is below 7.0%, though personalized targets vary. For older adults, those with frequent hypoglycemia, or those with significant comorbidities, slightly higher targets (7.5% or even 8.0%) may be appropriate. For younger patients and those early in the disease, tighter control (6.5%) is sometimes pursued.
How A1C changes correlate with kidney lab changes
The relationship between A1C and kidney lab trends is well-established.
Landmark trials (DCCT for type 1, UKPDS for type 2, ADVANCE, ACCORD) have shown that lower A1C is associated with reduced kidney disease progression. Every 1 percentage point reduction in A1C corresponds to roughly a 20 to 30 percent reduction in microvascular complications, including kidney disease.
In clinical practice, the pattern usually looks like:
Well-controlled A1C (below 7.0% consistently) for years → slower progression of any kidney involvement, or no kidney involvement at all.
Moderately controlled A1C (7.0–8.0%) for years → variable kidney outcomes, with many patients developing some degree of microalbuminuria over decades but progression often slow.
Poorly controlled A1C (above 8.0% chronically) → accelerated kidney damage risk. Microalbuminuria more likely, and progression from microalbuminuria to more significant disease more likely.
The correlation isn't perfect because other factors matter: blood pressure, duration of diabetes, genetics, other medications, concurrent conditions. Some patients with excellent A1Cs develop kidney disease anyway; some with mediocre A1Cs don't. But as a general trend, A1C and long-term kidney outcomes move together.
The lag between A1C changes and kidney lab changes is worth knowing. A sustained improvement in A1C doesn't immediately improve eGFR or ACR. Protective effects on kidneys accumulate over months to years. This is why consistency matters more than perfection in any given quarter.
What to track at home between labs
The gap between lab visits (usually 3 to 6 months for A1C and kidney labs together) is where home tracking fills in the picture.
Blood sugar patterns. If you have a CGM, your time-in-range data supplements A1C in useful ways. 70 percent or more time in range (70–180 mg/dL) is a reasonable target for most adults. Patterns of frequent highs, frequent lows, or wide variability matter independent of what A1C shows.
Urine color daily. Pale to medium yellow consistently is the target. Persistent darker readings despite good hydration, or any appearance of foam, is worth noting for your next appointment. The post on blood sugar and urine color covers the specific patterns.
Blood pressure weekly (or daily if hypertensive). Blood pressure affects kidney outcomes as much as blood sugar for diabetics. A home cuff is underused and high-value.
Weight monthly. A stable weight is generally good. Unexplained weight gain over weeks can indicate fluid retention; unexplained loss can indicate other issues.
Symptom awareness. Fatigue beyond your baseline, new swelling, persistent foam, increased urination — all worth noting.
Apps like Urivia let you log urine color, hydration, and symptoms together, which makes it easier to see correlations with your glucose and blood pressure data. The goal is integrated pattern tracking, not isolated numbers.
Reading the two together
When you sit down with fresh labs and your home tracking, a few integration questions clarify your situation.
Is my A1C stable or trending? Compare to the previous year's values. Stable at target is good. Drifting upward despite consistent effort suggests something needs to change. Declining toward lower targets is a positive trend, though avoid the aggressive pursuit of below-target A1C if it's causing significant hypoglycemia.
Is my kidney function stable or trending? Look at eGFR and ACR over the past several readings, not just the most recent. Stable is good. Declining eGFR or rising ACR warrants attention, ideally through adjustments that happen before the trend accelerates.
Do the two trends match? Improving A1C and stable kidney function is expected. Worsening A1C and worsening kidney function is also expected — poor control driving damage. The harder-to-interpret situations are mismatches: improving A1C with worsening kidney function (suggests damage already done, or non-diabetic kidney issues), or worsening A1C with stable kidney function (possibly early stages of damage not yet showing in labs).
Are my home observations consistent with the labs? If your labs look fine but you've been noticing persistent foam, dark urine, or swelling, raise those specific observations at your appointment. Sometimes labs take a beat to catch what you're seeing at home.
The post on reading your kidney labs covers eGFR, creatinine, BUN, and ACR interpretation in detail.
The long view — years, not weeks
Diabetes management and kidney outcomes play out over decades. The single-visit mindset — where each appointment feels like an isolated event — misses the forest.
Keep a personal record of your A1C and kidney labs over time. Patient portals usually allow export. A simple spreadsheet organized by date, with A1C, eGFR, creatinine, ACR, and blood pressure in columns, reveals patterns that scrolling through individual visit records doesn't.
After 3 to 5 years of data, your trajectory is usually clear: broadly stable, gradually improving, or gradually deteriorating. Each of these calls for different attention from your care team.
The patients who do best over decades aren't necessarily the ones with the perfect A1Cs. They're the ones whose care stays consistent — consistent medication adherence, consistent blood pressure control, consistent avoidance of kidney-stressing medications, consistent lab surveillance. Perfect single-visit numbers matter less than a trajectory that's moving in a sustainable direction.
How to track this yourself
Apps like Urivia let you log urine color, hydration, and symptoms alongside whatever glucose tracking you use, which helps fill in the between-lab picture. A paper journal or spreadsheet with your lab history, A1C, and home observations works equally well.
The post on type 2 diabetes and kidney function and diabetic kidney disease signs cover the broader context of what these labs together tell you.
When to see a doctor
Between regular appointments, call if: your A1C has increased significantly and you're not sure why; your kidney labs have changed meaningfully from baseline; you've noticed persistent symptoms (foam, swelling, fatigue, increased urination) across weeks; you've had a period of illness, dehydration, or medication changes that may have affected your labs.
Go to urgent care or the ER for any of the standard diabetic emergencies: DKA symptoms; severe dehydration with confusion; severely uncontrolled blood sugar with symptoms; acute kidney changes.
Frequently asked questions
How often should A1C and kidney labs be tested together?
For most adults with diabetes, every 3 to 6 months for A1C, at least annually for full kidney labs (eGFR, creatinine, ACR). More often if either is abnormal or if you've recently changed medications. Your doctor sets the specific cadence.
What A1C is safe for my kidneys?
Below 7.0% for most adults with diabetes. Tighter control (closer to 6.5%) may be pursued for younger patients with short disease duration. Slightly higher targets (7.5% or 8.0%) are appropriate for older patients or those with frequent hypoglycemia. The specific target matters less than consistency with whatever your doctor agrees on as your target.
Can A1C be accurate in CKD?
It can be misleading in patients with significant kidney disease because reduced red blood cell lifespan (common in CKD) can artificially lower A1C. In patients with stage 3b or later CKD, alternative markers (fructosamine, CGM time-in-range) sometimes provide additional context. Discuss with your nephrologist and endocrinologist if this applies to you.
Does lowering A1C reverse kidney damage?
It can slow or halt progression and in some early cases modestly improve lab values (especially microalbuminuria). Established structural kidney damage usually doesn't reverse, but stabilization is often achievable. The earlier in kidney disease you improve A1C, the more benefit.
What's more important for kidneys — A1C or blood pressure?
Both matter significantly. For most diabetics, they're nearly equally important for long-term kidney outcomes. Blood pressure control may even edge ahead in some patients, particularly those with established kidney disease. You want both in target range; neither substitutes for the other.
Can GLP-1 medications lower A1C and protect kidneys?
Yes, both. GLP-1 medications (semaglutide, liraglutide, tirzepatide, dulaglutide) lower A1C substantially and have demonstrated kidney-protective effects in major trials. For patients with type 2 diabetes and kidney risk factors, they're often among the preferred options. The post on Ozempic kidney side effects covers the specifics.
What if my A1C is stable but my ACR is rising?
This pattern suggests kidney involvement that's happening despite adequate glucose control. It warrants attention. Typical next steps: optimizing blood pressure control, starting or adjusting an ACE inhibitor or ARB, adding an SGLT2 inhibitor or GLP-1 if not already on one, and investigating whether other factors (medication effects, concurrent conditions) are contributing. Don't assume stable A1C means kidneys are safe.